Atlas Trials

Gene Expression Profile of Resected Pancreatic and Ampullary Adenocarcinoma at Favorable Prognosis

Clinical trial NCT05754788 · UNKNOWN

Trial details

NCT number
NCT05754788
Sponsor
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Status
UNKNOWN
Study type
OBSERVATIONAL
Resectable Pancreatic Adenocarcinoma
Start date
2022-09-19
Primary completion
2023-05-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.